We are live on ! Find out more
PJP icon

Invesco Pharmaceuticals ETF
PJP

119 hedge funds and large institutions have $151M invested in Invesco Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

118% more capital invested

Capital invested by funds: $69.2M → $151M (+$81.8M)

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

15.89% more ownership

Funds ownership: 21.99% → 37.88% (+16%)

13% more funds holding

Funds holding: 105 → 119 (+14)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $259K

Holders
119
Holders Change
+14
Holders Change %
+13.33%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
33
Reduced
21
Closed
11
Calls
–
Puts
$259K
Net Calls
-$259K
Net Calls Change
-$259K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$24.4M
2
HighTower Advisors
HighTower Advisors
Illinois
+$23.4M
3
Bank of America
Bank of America
North Carolina
+$5.51M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$5.45M
5
CI
Cavalier Investments
Georgia
+$4.85M

Top Sellers

Rank Fund Capital Flow
1
WI
WBI Investments
New Jersey
-$739K
2
IDA
Intelligence Driven Advisers
California
-$565K
3
HAS
HBW Advisory Services
California
-$533K
4
GC
Grimes & Company
Massachusetts
-$502K
5
BlackRock
BlackRock
New York
-$367K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
$59K -$5.28K -50 -8%
FFA
77
Farther Finance Advisors
California
$48.7K +$49.2K +466 New
NEWAS
78
N.E.W. Advisory Services
Wisconsin
$48.2K +$106 +1 +0.2%
AAP
79
Arax Advisory Partners
Colorado
$46.4K +$47.2K +447 New
GAA
80
Global Assets Advisory
Florida
$41.5K +$42.3K +400 New
IA
81
IFP Advisors
Florida
$40.5K -$5.28K -50 -11%
FFL
82
Financial Freedom LLC
Ohio
$40.2K +$106 +1 +0.3%
DFA
83
DHJJ Financial Advisors
Illinois
$36.2K +$211 +2 +0.6%
Fifth Third Bancorp
84
Fifth Third Bancorp
Ohio
$36K +$36.7K +347 New
OSAM
85
O'Shaughnessy Asset Management
Connecticut
$33.1K +$29.7K +281 +739%
GI
86
GAMMA Investing
California
$25K -$19.8K -187 -44%
BlackRock
87
BlackRock
New York
$23.9K -$367K -3,470 -94%
NA
88
NewEdge Advisors
Louisiana
$22.3K – – –
ACA
89
Aptus Capital Advisors
Alabama
$21.3K – – –
ASN
90
Advisory Services Network
Georgia
$17.1K +$17.4K +165 New
RF
91
Rossby Financial
Florida
$16.8K – – –
HIA
92
Harbor Investment Advisory
Maryland
$15.6K – – –
HB
93
Horizon Bancorp
Indiana
$15K – – –
Carson Wealth (CWM LLC)
94
Carson Wealth (CWM LLC)
Nebraska
$14K – – –
FDCDDQ
95
Federation des caisses Desjardins du Quebec
Quebec, Canada
$13.4K – – –
HFS
96
Hantz Financial Services
Michigan
$12K – – –
MMCM
97
Murphy & Mullick Capital Management
New York
$11.9K – – –
MSG
98
Main Street Group
Virginia
$11K +$11.2K +106 New
HCM
99
Hollencrest Capital Management
California
$10.5K – – –
CBT
100
Crews Bank & Trust
Florida
$10.4K – – –
2 3
4
5 6

PJP Hedge Fund Activity: Q1 2026 in Review

119 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2026, worth a combined $151M — up 118% from $69.2M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new PJP positions and 11 closed out — a net gain of 17 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $24.4M. The largest seller was WBI Investments, exiting entirely with an estimated $739K sold.

  • 119 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2026, up from 105 in Q4 2025.
  • Funds reported $151M of Invesco Pharmaceuticals ETF stock for Q1 2026, up 118% quarter-over-quarter.
  • 28 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2026 and 11 closed out, a net change of +17 holders.
  • The largest Invesco Pharmaceuticals ETF buyer in Q1 2026 was Morgan Stanley, an estimated $24.4M added.
  • The largest Invesco Pharmaceuticals ETF seller in Q1 2026 was WBI Investments, an estimated $739K sold.

Based on aggregated 13F filings for Q1 2026.